Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
NASDAQ · Healthcare
Amylyx Pharmaceuticals, Inc. Common Stock Balance Sheet 2021–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 332.6M | 193.6M | 517.5M | 391.5M | 105.6M |
| Cash & Equivalents | 226.7M | 77.4M | 170.2M | 62.5M | 50.2M |
| Liabilities | |||||
| Total Liabilities | 27.4M | 28.9M | 84.0M | 50.8M | 17.4M |
| Long-Term Debt | — | — | — | — | — |
| Equity | |||||
| Shareholders' Equity | 305.3M | 164.8M | 433.4M | 340.6M | -151.2M |
Amylyx Pharmaceuticals, Inc. Common Stock Balance Sheet — FAQ
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) balance sheet over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMLX's balance sheet history?
The chart and table above show Amylyx Pharmaceuticals, Inc. Common Stock's balance sheet by year and by quarter, including the growth rate.